All News #Library
Stemline Therapeutics` Orserdu (elacestrant) Receives Approval in Europe
09 Oct 2023 //
EMA
Stemline`s Biologic Elzonris (Tagraxofusp) Receives Approval in the U.S.
03 Nov 2022 //
FDA
Stemline`s Biologic Elzonris (Tagraxofusp) Receives Approval in the U.S.
27 Oct 2022 //
FDA

Market Place
Sourcing Support